Axim Biotechnologies annual gross margin
2015
2016
2017
2018
2019
2023
2024
Axim Biotechnologies Gross Margin Growth & History (AXIM)
Axim Biotechnologies's gross margin was 89.59% for fiscal 2024.
View full Axim Biotechnologies company overviewAxim Biotechnologies annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 89.59% | −10.41 pp |
| 2023 | 2023-12-31 | 100.00% | — |
| 2019 | 2019-12-31 | 0.00% | −95.65 pp |
| 2018 | 2018-12-31 | 95.65% | +85.74 pp |
| 2017 | 2017-12-31 | 9.91% | +237.44 pp |
| 2016 | 2016-12-31 | −227.53% | −224.99 pp |
| 2015 | 2015-12-31 | −2.54% | — |
Axim Biotechnologies quarterly gross margin
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q4.19
Q1.21
Q2.21
Q3.21
Q3.22
Q2.23
Q2.24
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-06-30 | 90.02% | −9.98 pp |
| Q2 2023 | 2023-06-30 | 100.00% | — |
| Q3 2022 | 2022-09-30 | 100.00% | 0.00 pp |
| Q3 2021 | 2021-09-30 | 100.00% | — |
| Q2 2021 | 2021-06-30 | 100.00% | — |
| Q1 2021 | 2021-03-31 | 100.00% | — |
| Q4 2019 | 2019-12-31 | −2.32% | −101.51 pp |
| Q1 2019 | 2019-03-31 | 74.32% | −13.69 pp |
| Q4 2018 | 2018-12-31 | 99.19% | +4.35 pp |
| Q3 2018 | 2018-09-30 | 48.99% | −34.16 pp |
| Q2 2018 | 2018-06-30 | 72.09% | +11.85 pp |
| Q1 2018 | 2018-03-31 | 88.01% | +197.09 pp |
| Q4 2017 | 2017-12-31 | 94.84% | +921.50 pp |
| Q3 2017 | 2017-09-30 | 83.15% | +125.45 pp |
| Q2 2017 | 2017-06-30 | 60.25% | +67.73 pp |
| Q1 2017 | 2017-03-31 | −109.08% | −100.44 pp |
| Q4 2016 | 2016-12-31 | −826.66% | −812.78 pp |
| Q3 2016 | 2016-09-30 | −42.30% | +9.62 pp |
| Q2 2016 | 2016-06-30 | −7.48% | −107.48 pp |
| Q1 2016 | 2016-03-31 | −8.63% | — |
| Q4 2015 | 2015-12-31 | −13.88% | — |
| Q3 2015 | 2015-09-30 | −51.92% | — |
| Q2 2015 | 2015-06-30 | 100.00% | — |
Axim Biotechnologies gross margin trends
Over the last five fiscal years, Axim Biotechnologies's gross margin increased from 0.00% to 89.59%, a change of +89.59 percentage points. The latest reported quarter, Q2 2024, shows 90.02%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Axim Biotechnologies source filings ↗